Angelique buys ESRX 70.61: Cleveland Research's Rating Change Only Had Short-term Impact, Express Scripts Up 1.0% (ESRX)
One week ago Express Scripts (NASDAQ:ESRX) was downgraded from Buy to Neutral at Cleveland Research. The stock closed at $67.28, which is 1.0% higher than the price one week ago ($66.64). Express Scripts, Inc is a full service pharmacy benefit management . ... ...
62 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home